Albumin-binding interactions of sodium valproate
- PMID: 6776162
- DOI: 10.1002/j.1552-4604.1980.tb02544.x
Albumin-binding interactions of sodium valproate
Abstract
In vitro equilibrium dialysis experiments show that salicylate and phenylbutazone displace valproate from its binding sites on human serum albumin at therapeutic concentrations, whereas warfarin and carbamazepin do not.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
